Brief: An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing
09/04/2026 23:03
April 9 (Reuters) - AN2 Therapeutics Inc ANTX.O: AN2 THERAPEUTICS INC - MAY OFFER AND SELL UP TO $300 MILLION OF SECURITIES - SEC FILING AN2 THERAPEUTICS INC - SELLING SECURITYHOLDERS MAY OFFER UP TO 14.04 MILLION SHARES OF COMMON STOCK - SEC FILING AN2 THERAPEUTICS INC - MAY OFFER UP TO $80 MILLION OF COMMON STOCK UNDER AGREEMENT WITH JEFFERIES LLC - SEC FILING Source text: [ID:n0001193125-26-149869] Further company coverage: ANTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview